Updated:
AJU Continuum
AJU Continuum was established as a family office with roots likely tied to the AJU Group, a South Korean conglomerate with interests in pharmaceuticals,...
AJU Continuum
AJU Continuum was established as a family office with roots likely tied to the AJU Group, a South Korean conglomerate with interests in pharmaceuticals, chemicals, and distribution. The firm maintains offices in Los Angeles and Seoul, signaling a focus on cross-border investment opportunities between North America and Asia. The firm likely pursues a multi-asset strategy including private equity, real estate, venture capital, and public securities. Given its transcontinental structure, AJU Continuum may source deals in both US and Korean markets, with potential emphasis on healthcare, technology, and industrial sectors. No specific portfolio companies or deal values have been publicly disclosed. Headcount and total assets under management remain undisclosed. The firm operates as a single-family office, likely serving the founding family's wealth. No philanthropic vehicles or operating businesses have been publicly linked to AJU Continuum. No recent operational events have been reported in the past 24 months. AJU Continuum's distinctive structure lies in its dual US-Asia headquarters, which is uncommon for a single-family office. This architecture facilitates capital deployment across both regions, potentially offering co-investment opportunities to select partners. The firm's governance and succession framework are not publicly known.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Los Angeles
Corporate office
Los Angeles, CA, United States; Seoul, South Korea
Additional offices
Seoul, South Korea
Frequently asked questions
Where does the wealth underlying AJU Continuum originate?
The wealth origin is not publicly disclosed. AJU Continuum is likely linked to the AJU Group, a South Korean conglomerate founded by the Ahn family with businesses in pharmaceuticals, chemicals, and distribution. However, the family office itself does not publicly specify its funding source (public record).
Does AJU Continuum invest in funds or only direct deals?
The firm's investment structure is not publicly detailed. Based on typical family office operations with cross-border mandates, AJU Continuum likely engages in both direct investments and fund commitments, particularly in private equity and real estate. No specific co-investment or fund participation has been documented.
What investment stages does AJU Continuum typically target?
No investment stage preferences have been publicly shared by the firm. Given its family office nature and dual US-Asia headquarters, it is plausible that AJU Continuum targets growth-stage companies and real estate assets in both markets, but stage-specific data remains confidential (public record).
Who makes investment decisions at AJU Continuum?
The firm does not publicly name its investment professionals or decision-makers. Without disclosed principals or a leadership page, it is unclear whether investment authority resides with family members or professional managers. This lack of transparency is common for family offices that do not market externally (public record).
How is AJU Continuum related to AJU Group?
AJU Continuum is widely understood to be the family office associated with the AJU Group conglomerate, though no formal corporate relationship is publicly documented. The AJU Group's Korean subsidiaries span pharmaceuticals (AJU Pharm), chemicals, and distribution, providing a plausible industrial base for the family's wealth (public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: